From to electronic health records to clinical trials, Food and Drug Administration decisions to the BRAIN initiative, The Motley Fool's health-care team sits down each week to discuss the most fascinating developments in health care and their implications for long-term investors. In this week's edition, the team talks about new trends in the health care industry, the week's biggest stock moves, and two stocks that investors need to watch.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
This Week in Health Care
For the week ended May 3, 2013.
David Williamson and Max Macaluso, Ph.D. have no position in any stocks mentioned. The Motley Fool recommends Athenahealth, Celgene, Express Scripts, Gilead Sciences, Johnson & Johnson, and WellPoint. The Motley Fool owns shares of Dendreon, Express Scripts, Johnson & Johnson, and WellPoint. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.